These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17681609)

  • 1. Preconditioning and postconditioning: united at reperfusion.
    Hausenloy DJ; Yellon DM
    Pharmacol Ther; 2007 Nov; 116(2):173-91. PubMed ID: 17681609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.
    Hausenloy DJ; Tsang A; Yellon DM
    Trends Cardiovasc Med; 2005 Feb; 15(2):69-75. PubMed ID: 15885573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preconditioning and postconditioning: new strategies for cardioprotection.
    Hausenloy DJ; Yellon DM
    Diabetes Obes Metab; 2008 Jun; 10(6):451-9. PubMed ID: 17825079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
    Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
    Hausenloy DJ; Yellon DM
    Heart Fail Rev; 2007 Dec; 12(3-4):217-34. PubMed ID: 17541822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial permeability transition pore and postconditioning.
    Gateau-Roesch O; Argaud L; Ovize M
    Cardiovasc Res; 2006 May; 70(2):264-73. PubMed ID: 16581044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ischemic postconditioning protects hypertrophic myocardium by ERK1/2 signaling pathway: experiment with mice].
    Li XM; Ma YT; Yang YN; Zhang JF; Chen BD; Liu F; Huang Y; Han W; Gao XM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):846-50. PubMed ID: 19595127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological targets revealed by myocardial postconditioning.
    Burley DS; Baxter GF
    Curr Opin Pharmacol; 2009 Apr; 9(2):177-88. PubMed ID: 19109069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial protection in reperfusion with postconditioning.
    Vinten-Johansen J; Zhao ZQ; Jiang R; Zatta AJ
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1035-45. PubMed ID: 16292995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postconditioning protects human atrial muscle through the activation of the RISK pathway.
    Sivaraman V; Mudalagiri NR; Di Salvo C; Kolvekar S; Hayward M; Yap J; Keogh B; Hausenloy DJ; Yellon DM
    Basic Res Cardiol; 2007 Sep; 102(5):453-9. PubMed ID: 17546527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past and present course of cardioprotection against ischemia-reperfusion injury.
    Liem DA; Honda HM; Zhang J; Woo D; Ping P
    J Appl Physiol (1985); 2007 Dec; 103(6):2129-36. PubMed ID: 17673563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
    Balakumar P; Rohilla A; Singh G; Singh K; Singh M
    Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial permeability transition pore as a target for preconditioning and postconditioning.
    Hausenloy DJ; Ong SB; Yellon DM
    Basic Res Cardiol; 2009 Mar; 104(2):189-202. PubMed ID: 19242644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning.
    Tamareille S; Mateus V; Ghaboura N; Jeanneteau J; Croué A; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Nov; 106(6):1329-39. PubMed ID: 21833651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unresolved issues in myocardial reperfusion injury.
    Buja LM; Weerasinghe P
    Cardiovasc Pathol; 2010; 19(1):29-35. PubMed ID: 19026571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent inhibition of mitochondrial permeability transition by preconditioning during the first hours of reperfusion.
    Argaud L; Loufouat J; Gateau-Roesch O; Gomez L; Robert D; Ovize M
    Shock; 2008 Nov; 30(5):552-6. PubMed ID: 18317409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.